Although the almost all U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade on the counter (OTC), a marijuana that is few are traded from the NASDAQ. Some investors choose shares which are noted on the NASDAQ with other exchanges for their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For instance, because the cannabis industry has exploded in current months and years, uplisting from an OTC market to a professional U.S. trade happens to be an advertising achievement for all marijuana that is rising. (For related reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)
An number that is increasing of businesses are now being noted on reputable U.S. exchanges in place of being exchanged regarding the OTC market reflecting the quick development of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ had been initial electronic trade and is certainly similar to technology and biotechnology. The cannabis businesses from the NASDAQ mirror this, therefore the almost all them operate into the biotech area of the industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of the total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is just a biotech business mixed up in production of medical cannabis medications. Research and development around Arena’s APD371 may be the primary focus associated with the company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is really a blank check business that is in a merger agreement with Kalyx developing Inc. Kalyx is a number one owning a home trust in the regulated cannabis industry in the us.
- The cannabis industry, especially the section of cannabis and biotech, is attracting significant investor attention.
- Cannabis will be used in new medications for the treating discomfort and many chronic, inflammatory, and fibrotic conditions.
- Organizations may also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic disorders, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is really a clinical-stage biotechnology company focused on developing and commercializing new chemical entities for the indications of discomfort and pruritus (itching). Although all the company’s clinical-stage items target opioid receptors, Cara happens to be performing preclinical research on cannabinoids to treat neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech company. The team’s research, development, and production are based around cannabis medications that seek to deal with chronic, inflammatory, fibrotic, as well as other diseases.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is really A canadian cannabis business. The team has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not only with extra money to fund its continued expansion but in addition by having a well-established partner skilled into the advertising of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage add-ons and vaporization gear and services and products to retail customers in the U.S. and Canada. Also, it runs websites that are e-commerce extra product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is developing a portfolio of cannabinoid medications. These medicines consist of Sativex for the treatment of spasticity associated with sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations outside of the united states of america and has received approval that is regulatory other nations. Epidiolex received Food And Drug Administration approval as being a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, very early beginning epilepsy without good current treatment plans. Other indications show that GW Pharmaceuticals is developing cannabinoid items for autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is a clinical-stage biopharmaceutical business that is developing medications centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant wellness products. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal to be used on cannabis plants into the Ca cultivation market.
Modern Age Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is really a manufacturer of beverages based on yerba mate, green tea extract, kombucha, and similar services and products. In current months, modern age has expanded its beverage offerings to include CBD infusions also, bringing it to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, which makes it probably the most present cannabis businesses to record in the exchange that is popular. The organization has been rapidly expanding its manufacturing ability and can even have the ability to create up to 113,000 kilograms of product per cbd oil by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation operates within the enforcement sector. The business’s business operations support medication screening through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a short cost boost) whenever it announced the production of an innovative new Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is really a specialty clinical-stage pharmaceutical business concentrated regarding the growth of cannabinoid-based drugs. Therapix’s present pipeline includes items targeted for the treatment of Tourette problem and mild impairment that is cognitive.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the initial marijuana-related business to have a short public offering (IPO) in the United States. The Nanaimo, Vancouver Island-based company focuses on medical cannabis products.
Village Farms International (NASDAQ:VFF)
Village Farms Overseas is considered the most present cannabis stock to begin exchanging from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The business features a history that is decades-long greenhouse produce manufacturing and it has just recently shifted a number of its focus toward cannabis production.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted from the growth of artificial treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two drugs being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and Fragile X syndrome.